EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Nanomedicines targeting activated immune cells and effector cells for rheumatoid arthritis treatment

Yasi Deng, Hao Zheng, Bin Li, Feibing Huang, Yun Qiu, Yupei Yang, Wenbing Sheng, Caiyun Peng, Xing Tian, Wei Wang, Huanghe Yu

Journal of Controlled Release · 2024-07 · 371 · 498-515

DOI: 10.1016/j.jconrel.2024.06.010 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Controlled Release, 2024-07. Verfasst von Yasi Deng und 10 weiteren Autor:innen. Beteiligte Einrichtung: TCM and Ethnomedicine Innovation & Development International Laboratory, Innovative Materia Medica Research Institute, School of Pharmacy, Hunan Univ…. Hauptthemen laut MEDLINE: Arthritis, Rheumatoid, Nanomedicine, Nanoparticles. Die Arbeit wurde bisher 39-mal zitiert (Crossref) und nennt 163 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Rheumatoid arthritis (RA) is a chronic systemic autoimmune disease characterized by synovial inflammation and inflammatory cellular infiltration. Functional cells in the RA microenvironment (RAM) are composed of activated immune cells and effector cells. Activated immune cells, including macrophages, neutrophils, and T cells, can induce RA. Effector cells, including synoviocytes, osteoclasts, and chondrocytes, receiving inflammatory stimuli, exacerbate RA. These functional cells, often associated with the upregulation of surface-specific receptor proteins and significant homing effects, can secrete pro-inflammatory factors and interfere with each other, thereby jointly promoting the progression of RA. Recently, some nanomedicines have alleviated RA by targeting and modulating functional cells with ligand modifications, while other nanoparticles whose surfaces are camouflaged by membranes or extracellular vesicles (EVs) of these functional cells target and attack the lesion site for RA treatment. When ligand-modified nanomaterials target specific functional cells to treat RA, the functional cells are subjected to attack, much like the intended targets. When functional cell membranes or EVs are modified onto nanomaterials to deliver drugs for RA treatment, functional cells become the attackers, similar to arrows. This study summarized how diversified functional cells serve as targets or arrows by engineered nanoparticles to treat RA. Moreover, the key challenges in preparing nanomaterials and their stability, long-term efficacy, safety, and future clinical patient compliance have been discussed here.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Arthritis, RheumatoidNanomedicineNanoparticlesHumansAnimalsDrug Delivery SystemsAntirheumatic AgentsExtracellular Vesicles

Stichwörter der Autor:innen

BiomaterialsFunctional cellsNanomaterialsRheumatoid arthritis (RA)Target and arrowTargeted drug delivery

Substanzen

Antirheumatic Agents

Autor:innen und Institutionen

  • TCM and Ethnomedicine Innovation & Development International Laboratory, Innovative Materia Medica Research Institute, School of Pharmacy, Hunan University of Chinese Medicine, Changsha 410208, China.
  • TCM and Ethnomedicine Innovation & Development International Laboratory, Innovative Materia Medica Research Institute, School of Pharmacy, Hunan University of Chinese Medicine, Changsha 410208, China. Electronic address…

Zitieren

APA

Deng, Y., Zheng, H., Li, B., Huang, F., Qiu, Y., Yang, Y., Sheng, W., Peng, C., Tian, X., Wang, W., & Yu, H. (2024). Nanomedicines targeting activated immune cells and effector cells for rheumatoid arthritis treatment. Journal of Controlled Release, 371, 498-515. https://doi.org/10.1016/j.jconrel.2024.06.010

Vancouver

Deng Y, Zheng H, Li B, Huang F, Qiu Y, Yang Y, et al. Nanomedicines targeting activated immune cells and effector cells for rheumatoid arthritis treatment. Journal of Controlled Release. 2024;371:498-515. doi:10.1016/j.jconrel.2024.06.010

BibTeX
@article{Deng2024,
  author = {Deng, Yasi and Zheng, Hao and Li, Bin and Huang, Feibing and Qiu, Yun and Yang, Yupei and Sheng, Wenbing and Peng, Caiyun and Tian, Xing and Wang, Wei and Yu, Huanghe},
  title = {Nanomedicines targeting activated immune cells and effector cells for rheumatoid arthritis treatment},
  journal = {Journal of Controlled Release},
  year = {2024},
  volume = {371},
  pages = {498--515},
  doi = {10.1016/j.jconrel.2024.06.010}
}
Kostenlos starten →